FDA-approved GLP-1 medications have been shown in clinical studies to support weight management and metabolic health, but they often come with higher out-of-pocket costs, and insurance coverage varies widely
Yasuda H, Yoshida K, Yasuda Y, Tsutsui T
If sodium is below 120 mEq/L, a continuous intravenous infusion is required
No trial is touching that question yet
Since 2020, the number of prescriptions made for these drugs has tripled, and its estimated that 12% of Americans have used these medications
Some users do lose weight, but that usually reflects diet, activity, and motivation changes happening at the same time, not the patch itself crossing the skin barrier and acting like a drug